Construction of the multivalent DNA vaccine pVIVO_2SjFABP-23 and its immuno-protection in mice
Shi You-en
Abstract
Shi You-en
Abstract
The multivalent DNA vaccine pVIVO_2SjFABP-23 was constructed and its immuno-protection to Schistosoma japonicum was investigated in mice,in which two couples of specific primers were designed according to gene sequences of Sj-FABP(fatty acid binding protein) and Sj-23(23kDa membrane protein),and these two gene fragments were spliced through a linker sequence by recombinant PCR technique to obtain the fusion gene Sj-FABP-23,which was inserted into vector pGEM-T,identified by restriction analysis digested with BamHI and EcoR1 and then cloned into expression plasmid pVIVO_2/MCS and transformed to E.coli GT110.The recombinant plasmid pVIVO_2-SjFABP-23 was extracted,purified and then inoculated to BALB/c mice through intramuscular route.Mice were challenged with cercariae of S.japonicum 4 weeks after inoculation,and killed to get specimens to count the adult worms and eggs.The experimental results showed that a target fragment with an obvious band of 1.1 kb demonstrated by electrophoresis of SjFABP-23 on 0.7% agarose gel could be amplified by PCR,and inoculation with this fragment into mice induced the reduction of the adult worm counts up to 52.14% and those of eggs up to 60.93% in comparison with those of control group of mice inoculated with blank plasmid pVIVO_2 intrtamuscularly at the same dosage of 100 μ per mouse.It is concluded that the multivalent DNA vaccine expressing SjFABP-23 was successfully constructed and this DNA vaccine demonstrates certain immuno-protection to S.japonicum infection in mice.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The multivalent DNA vaccine pVIVO_2SjFABP-23 was constructed and its immuno-protection to Schistosoma japonicum was investigated in mice,in which two couples of specific primers were designed according to gene sequences of Sj-FABP(fatty acid binding protein) and Sj-23(23kDa membrane protein),and these two gene fragments were spliced through a linker sequence by recombinant PCR technique to obtain the fusion gene Sj-FABP-23,which was inserted into vector pGEM-T,identified by restriction analysis digested with BamHI and EcoR1 and then cloned into expression plasmid pVIVO_2/MCS and transformed to E.coli GT110.The recombinant plasmid pVIVO_2-SjFABP-23 was extracted,purified and then inoculated to BALB/c mice through intramuscular route.Mice were challenged with cercariae of S.japonicum 4 weeks after inoculation,and killed to get specimens to count the adult worms and eggs.The experimental results showed that a target fragment with an obvious band of 1.1 kb demonstrated by electrophoresis of SjFABP-23 on 0.7% agarose gel could be amplified by PCR,and inoculation with this fragment into mice induced the reduction of the adult worm counts up to 52.14% and those of eggs up to 60.93% in comparison with those of control group of mice inoculated with blank plasmid pVIVO_2 intrtamuscularly at the same dosage of 100 μ per mouse.It is concluded that the multivalent DNA vaccine expressing SjFABP-23 was successfully constructed and this DNA vaccine demonstrates certain immuno-protection to S.japonicum infection in mice.
Key concepts: Schistosoma japonicum, DNA vaccination, Biology, Recombinant DNA, Plasmid, Molecular biology, Agarose gel electrophoresis, Virology